Evidence map›Paper›PMID 37452126›Full record

ArticleCommunications biology2023

The combined action of the intracellular regions regulates FGFR2 kinase activity.

Chi-Chuan Lin, Lukasz Wieteska, Guillaume Poncet-Montange, Kin Man Suen, Stefan T Arold, Zamal Ahmed, John E Ladbury

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Eph receptor signaling complexes in the plasma membrane.Trends in biochemical sciences · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Chi-Chuan LinSchool of Molecular and Cellular Biology, and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK.ORCID 0000-0003-3071-172X
Lukasz WieteskaSchool of Molecular and Cellular Biology, and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK.
Guillaume Poncet-MontangeCenter for the Development of Therapeutics, Broad Institute of MIT & Harvard, Cambridge, MA, 02142, USA.
Kin Man SuenSchool of Molecular and Cellular Biology, and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK.ORCID 0000-0001-9452-2528
Stefan T AroldKing Abdullah University of Science and Technology, Computational Bioscience Research Center, Division of Biological and Environmental Sciences and Engineering, Thuwal, 23955-6900, Saudi Arabia.
Zamal AhmedDepartment of Molecular and Cellular Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA.ORCID 0000-0003-3400-6577
John E LadburySchool of Molecular and Cellular Biology, and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK. j.e.ladbury@leeds.ac.uk.ORCID 0000-0002-6328-7200
University of Leeds · GBBroad Institute · USCentre National de la Recherche Scientifique · FRThe University of Texas MD Anderson Cancer Center · US

Funding

PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISMR01CA200231 · NCI · WASHINGTON UNIVERSITY · PI AHMED, ZAMAL, JONES, DARIN E. · 2016 to 2020
$1.7M
Cancer Research UK 22356NCI NIH HHS R01 CA200231
6 · The paper itself

Abstract

Receptor tyrosine kinases (RTKs) are typically activated through a precise sequence of intracellular phosphorylation events starting with a tyrosine residue on the activation loop (A-loop) of the kinase domain (KD). From this point the mono-phosphorylated enzyme is active, but subject to stringent regulatory mechanisms which can vary dramatically across the different RTKs. In the absence of extracellular stimulation, fibroblast growth factor receptor 2 (FGFR2) exists in the mono-phosphorylated state in which catalytic activity is regulated to allow rapid response upon ligand binding, whilst restricting ligand-independent activation. Failure of this regulation is responsible for pathologic outcomes including cancer. Here we reveal the molecular mechanistic detail of KD control based on combinatorial interactions of the juxtamembrane (JM) and the C-terminal tail (CT) regions of the receptor. JM stabilizes the asymmetric dimeric KD required for substrate phosphorylation, whilst CT binding opposes dimerization, and down-regulates activity. Direct binding between JM and CT delays the recruitment of downstream effector proteins adding a further control step as the receptor proceeds to full activation. Our findings underscore the diversity in mechanisms of RTK oligomerisation and activation.

Indexed as

Receptor, Fibroblast Growth Factor, Type 2TyrosineCell MembraneLigandsPhosphorylationLigandsReceptor, Fibroblast Growth Factor, Type 2Tyrosine

Identifiers

PMID37452126
PMCPMC10349056
OpenAlexW4384296559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.